| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.033 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |